Burning Rock Biotech (BNR) Income from Continuing Operations (2019 - 2026)
Burning Rock Biotech (BNR) posted quarterly Income from Continuing Operations of 2455457.17 for Q1 2026, down 36.76% year-over-year from 3882465.9 in Q1 2025, and down 25.99% on a QoQ basis from 1949000.0 in Q4 2025.
Burning Rock Biotech (BNR) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Burning Rock Biotech (BNR) has reported Income from Continuing Operations for 8 consecutive years, with 2455457.17 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 36.76% year-over-year to 2455457.17; the TTM figure through Mar 2026 stood at 7960469.91 (up 74.64% YoY), while the FY2025 annual figure was 7916000.0, up 83.33% from the prior year.
- Income from Continuing Operations came in at 2455457.17 for Q1 2026 at Burning Rock Biotech, down from 1949000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1273860.7 in Q2 2025, with the low at 41184386.88 in Q1 2022.
- Average Income from Continuing Operations over 5 years is 17159843.55, with a median of 16785000.0 recorded in 2024.
- Across the five-year window, Income from Continuing Operations tumbled 57.42% in 2022 and surged 91.43% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 30798000.0 in 2022, then gained by 26.79% to 22546000.0 in 2023, then jumped by 57.06% to 9681000.0 in 2024, then soared by 79.87% to 1949000.0 in 2025, then fell by 25.99% to 2455457.17 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 2455457.17, 1949000.0, and 2282152.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Burning Rock Biotech | 748.66 Mn | 683.48 Mn | 11.31 Mn | -2.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.46 Mn |
| Dec 31, 2025 | -1.95 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Mar 31, 2025 | -1.80 Mn |
| Dec 31, 2024 | -9.68 Mn |
| Sep 30, 2024 | -5.04 Mn |
| Jun 30, 2024 | -14.87 Mn |
| Mar 31, 2024 | -16.79 Mn |
| Dec 31, 2023 | -22.55 Mn |
| Sep 30, 2023 | -23.86 Mn |
| Jun 30, 2023 | -18.61 Mn |
| Mar 31, 2023 | -26.96 Mn |
| Dec 31, 2022 | -30.80 Mn |
| Sep 30, 2022 | -32.54 Mn |
| Jun 30, 2022 | -39.11 Mn |
| Mar 31, 2022 | -41.18 Mn |
| Dec 31, 2021 | -39.77 Mn |
| Sep 30, 2021 | -26.33 Mn |
| Jun 30, 2021 | -31.04 Mn |